An Overview of Osteoarthritis: Prevalence and Impact
Osteoarthritis (OA), the most frequently diagnosed type of arthritis, presents a global health concern impacting people around the world. This degenerative disease results from the gradual wear and tear of the cartilage, a critical component that acts as a buffer at the ends of the bones. Although osteoarthritis can target any joint in the body, it prevalently affects the hands, knees, hips, and spine.
Present in 7% of the global population, osteoarthritis affects more than 500 million individuals. Notably, the condition shows a predilection for women, significantly impacting their overall health and quality of life.
Innovative Approach to Osteoarthritis Treatment Through Stem Cell Therapies
In an attempt to introduce new, effective alternatives to conventional osteoarthritis treatments like knee replacement surgery, BioCellSupply / Viatacell Biologics has developed revolutionary stem cell therapiese geared towards providing high impact results for patients seeking non-invasive options for osteoarthritis management.
Stem cell therapy presents an innovative treatment approach for osteoarthritis, offering the potential for regeneration of damaged tissues and relief from the disease’s debilitating symptoms.
At their core, stem cells are unspecialized cells with the ability to differentiate into different types of specialized cells, including cartilage cells. Additionally, they have the potential to self-renew, thus maintaining their numbers over time.
In the context of osteoarthritis, the primary issue lies in the degradation of the cartilage within the joints. Conventional treatments such as pain relief medications, physical therapy, and surgical interventions like joint replacements aim to manage the symptoms or replace the damaged joint. However, they do not address the root of the problem – the loss of cartilage.
This is where stem cell therapy comes into the picture. By harnessing the regenerative potential of stem cells, the treatment aims to repair the worn-out cartilage, thus addressing the disease’s underlying cause.
In the procedure, stem cells are harvested from the patient’s body, often from the bone marrow or adipose (fat) tissue. After being processed in a lab to concentrate the stem cells, they are then reinjected directly into the affected joint.
Once in the joint, the stem cells can potentially differentiate into new cartilage cells and promote the repair of damaged tissues. In addition, stem cells can release anti-inflammatory substances that can help alleviate symptoms.